• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Addressing survivorship challenges in locally recurrent rectal cancer: Methodological considerations and future directions.

作者信息

Xu Manhong, Fu Huiting

机构信息

Shuguang Hospital Afiliated to Shanghai University of Traditional Chinese Medicine, Pudong, Shanghai, China.

出版信息

Colorectal Dis. 2025 May;27(5):e70116. doi: 10.1111/codi.70116.

DOI:10.1111/codi.70116
PMID:40357660
Abstract
摘要

相似文献

1
Addressing survivorship challenges in locally recurrent rectal cancer: Methodological considerations and future directions.应对局部复发性直肠癌的生存挑战：方法学考量与未来方向。
Colorectal Dis. 2025 May;27(5):e70116. doi: 10.1111/codi.70116.
2
Survivorship issues in long-term survivors of locally recurrent rectal cancer: A qualitative study.局部复发性直肠癌长期幸存者的生存问题：一项定性研究。
Colorectal Dis. 2025 Mar;27(3):e70051. doi: 10.1111/codi.70051.
3
Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!个体化新辅助治疗局部进展期直肠癌：一种方法并不适合所有人！
Colorectal Dis. 2021 Jul;23(7):1662-1669. doi: 10.1111/codi.15669. Epub 2021 Apr 22.
4
Pre-Treatment Gene Methylation Ratio Predicts Tumor Response to Total Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer.治疗前基因甲基化率可预测局部晚期直肠癌患者对全新辅助治疗的肿瘤反应。
Cancers (Basel). 2025 Mar 13;17(6):965. doi: 10.3390/cancers17060965.
5
Comparison of Standard Neoadjuvant Therapy and Total Neoadjuvant Therapy in Terms of Effectiveness in Patients Diagnosed with Locally Advanced Rectal Cancer.局部晚期直肠癌患者中标准新辅助治疗与全新辅助治疗有效性的比较
Medicina (Kaunas). 2025 Feb 14;61(2):340. doi: 10.3390/medicina61020340.
6
Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.局部晚期与局部复发性直肠癌行盆腔脏器切除术的手术结局和生活质量结局的差异。
Dis Colon Rectum. 2022 Dec 1;65(12):1475-1482. doi: 10.1097/DCR.0000000000002401. Epub 2022 Jul 27.
7
Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes?骶骨骨盆广泛切除术治疗局部复发性直肠癌：能否安全进行并获得良好的肿瘤学结果？
Dis Colon Rectum. 2014 Jan;57(1):47-55. doi: 10.1097/DCR.0000000000000015.
8
[Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].程序性死亡蛋白1（PD-1）抗体联合全新辅助放化疗治疗具有高危因素的局部进展期中低位直肠癌的短期疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Nov 25;24(11):998-1007. doi: 10.3760/cma.j.cn441530-20210927-00386.
9
[Controversies and progress in adjuvant chemotherapy for patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy].接受新辅助放化疗的局部晚期直肠癌患者辅助化疗的争议与进展
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jun 25;22(6):594-596. doi: 10.3760/cma.j.issn.1671-0274.2019.06.015.
10
Shared Decision Making in the Treatment of Rectal Cancer.直肠癌治疗中的共同决策
J Clin Med. 2025 Mar 26;14(7):2255. doi: 10.3390/jcm14072255.